|
RFT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.86632999999992E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.023080E-03 |
| Normal-vs-Stage2 |
1.540080E-02 |
| Normal-vs-Stage3 |
8.731800E-02 |
| Normal-vs-Stage4 |
2.794400E-01 |
| Stage1-vs-Stage2 |
3.371200E-01 |
| Stage1-vs-Stage3 |
9.763200E-01 |
| Stage1-vs-Stage4 |
7.802800E-01 |
| Stage2-vs-Stage3 |
4.833400E-01 |
| Stage2-vs-Stage4 |
4.244000E-01 |
| Stage3-vs-Stage4 |
8.429400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.95720000000832E-05 |
| Normal-vs-AfricanAmerican |
1.177380E-04 |
| Normal-vs-Asian |
2.683600E-01 |
| Caucasian-vs-AfricanAmerican |
3.807800E-01 |
| Caucasian-vs-Asian |
7.391700E-02 |
| AfricanAmerican-vs-Asian |
2.999900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.025900E-04 |
| Normal-vs-Female |
8.75340000483504E-08 |
| Male-vs-Female |
6.629300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.801300E-03 |
| Normal-vs-Extreme_Weight |
2.825900E-02 |
| Normal-vs-Obese |
4.584400E-04 |
| Normal-vs-Extreme_Obese |
2.937800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.324400E-01 |
| Normal_Weight-vs-Obese |
9.878000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.733400E-01 |
| Extreme_Weight-vs-Obese |
1.684010E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.204400E-01 |
| Obese-vs-Extreme_Obese |
6.401200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.244060E-02 |
| Normal-vs-Age(41-60Yrs) |
4.36290000005446E-06 |
| Normal-vs-Age(61-80Yrs) |
2.697600E-03 |
| Normal-vs-Age(81-100Yrs) |
1.260830E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.711200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.945770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.143000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.892300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.761400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.669200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.89760000002259E-06 |
| Normal-VS-Type2 PRCC |
2.505200E-01 |
| Normal-VS-KIRP CIMP |
1.171700E-02 |
| Normal-VS-Unclassified PRCC |
1.680380E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.702700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.413600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.283600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.183100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.541800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.417650E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.609000E-01 |
| Normal-vs-N1 |
4.849700E-02 |
| Normal-vs-N2 |
2.944500E-02 |
| N0-vs-N1 |
1.824770E-01 |
| N0-vs-N2 |
2.228000E-01 |
| N1-vs-N2 |
5.675600E-01 |
|
|
